Predictive value of C-reactive protein for radiographic spinal progression in axial spondyloarthritis in dependence on genetic determinants of fibrin clot formation and fibrinolysis.


Journal

RMD open
ISSN: 2056-5933
Titre abrégé: RMD Open
Pays: England
ID NLM: 101662038

Informations de publication

Date de publication:
06 2021
Historique:
received: 26 05 2021
accepted: 16 06 2021
entrez: 30 6 2021
pubmed: 1 7 2021
medline: 1 9 2021
Statut: ppublish

Résumé

Genetic determinants of fibrin clot formation and fibrinolysis have an impact on local and systemic inflammatory response. The aim of the present study was to assess whether coagulation-related genotypes affect the predictive value of C-reactive protein (CRP) in regards of radiographic spinal progression in axial spondyloarthritis (axSpA). Two hundred and eight patients with axSpA from the German Spondyloarthritis Inception Cohort were characterised for genotypes of α-fibrinogen, β-fibrinogen (FGB) and γ-fibrinogen, factor XIII A-subunit (F13A) and α Overall, CRP was associated with mSASSS progression ≥2 points: time-averaged CRP ≥10 mg/L, OR: 3.32, 95% CI 1.35 to 8.13. After stratification for coagulation-related genotypes, CRP was strongly associated with mSASSS progression in individuals predisposed to form loose, fibrinolysis-susceptible fibrin clots (FGB rs1800790GG, OR: 6.86, 95% CI 2.08 to 22.6; A2AP 6Trp, OR: 5.86, 95% CI 1.63 to 21.0; F13A 34Leu, OR: 8.72, 95% CI 1.69 to 45.1), while in genotypes predisposing to stable fibrin clots, the association was absent or weak (FGB rs1800790A, OR: 0.83, 95% CI 0.14 to 4.84; A2AP 6Arg/Arg, OR: 1.47, 95% CI 0.35 to 6.19; F13A 34Val/Val, OR: 1.72, 95% CI 0.52 to 5.71). Elevated CRP levels seem to be clearly associated with radiographic spinal progression only if patients are predisposed for loose fibrin clots with high susceptibility to fibrinolysis.

Identifiants

pubmed: 34187873
pii: rmdopen-2021-001751
doi: 10.1136/rmdopen-2021-001751
pmc: PMC8245464
pii:
doi:

Substances chimiques

Fibrin 9001-31-4
C-Reactive Protein 9007-41-4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Ann Rheum Dis. 2010 Aug;69(8):1465-70
pubmed: 20498215
J Clin Invest. 1997 Jun 15;99(12):3034-9
pubmed: 9185528
Lancet. 2003 Apr 26;361(9367):1424-31
pubmed: 12727396
Physiol Rev. 2011 Jul;91(3):931-72
pubmed: 21742792
Ann Rheum Dis. 2009 Jun;68(6):863-7
pubmed: 18628283
Ann Rheum Dis. 2016 Dec;75(12):2114-2118
pubmed: 27125522
Ann Rheum Dis. 2012 Apr;71(4):518-23
pubmed: 21989544
Blood. 2003 Jul 1;102(1):25-30
pubmed: 12456499
Curr Rheumatol Rep. 2017 Sep;19(9):55
pubmed: 28752489
Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):e88-99
pubmed: 21836064
Arthritis Rheum. 2012 May;64(5):1388-98
pubmed: 22127957
J Am Coll Cardiol. 2008 Sep 9;52(11):941-52
pubmed: 18772067
Thromb Res. 2007;120(5):727-31
pubmed: 17303222
Rheumatology (Oxford). 2018 Apr 1;57(4):703-711
pubmed: 29373733
Thromb Haemost. 1999 Aug;82(2):781-6
pubmed: 10605782
Blood. 2007 Jun 15;109(12):5286-92
pubmed: 17317851
Nat Rev Rheumatol. 2012 Dec;8(12):738-46
pubmed: 23147903
Ann Rheum Dis. 2012 Jul;71(7):1163-9
pubmed: 22267327
Blood. 2008 Feb 1;111(3):1282-6
pubmed: 18006701
Lancet. 2017 Jul 1;390(10089):73-84
pubmed: 28110981
Thromb Res. 2020 Jul;191:90-96
pubmed: 32408093
Adv Protein Chem. 2005;70:247-99
pubmed: 15837518
J Immunol. 1988 Apr 1;140(7):2340-9
pubmed: 3351302
Ann Rheum Dis. 2005 Jul;64(7):988-94
pubmed: 15958757
Blood. 2019 Feb 7;133(6):511-520
pubmed: 30523120
Arthritis Rheum. 2009 Mar;60(3):717-27
pubmed: 19248087
Arterioscler Thromb Vasc Biol. 2000 May;20(5):1354-61
pubmed: 10807754
Blood. 2011 Jun 16;117(24):6694-701
pubmed: 21505192
Ann Rheum Dis. 2014 Aug;73(8):1455-61
pubmed: 24812292
Thromb Haemost. 2009 Feb;101(2):317-24
pubmed: 19190816
Ann Rheum Dis. 2013 Aug;72(8):1430-2
pubmed: 23625981
Ann Rheum Dis. 2016 Aug;75(8):1486-93
pubmed: 26462728
Nat Med. 2005 Mar;11(3):298-304
pubmed: 15723073
J Thromb Haemost. 2006 Jun;4(6):1279-87
pubmed: 16706972
RMD Open. 2015 Sep 14;1(1):e000153
pubmed: 26535153
Epidemiology. 2007 Nov;18(6):800-4
pubmed: 18049194
Blood. 2015 Jan 15;125(3):427-37
pubmed: 25336631
Ann Rheum Dis. 2014 Oct;73(10):1819-25
pubmed: 23852807
RMD Open. 2019 Feb 26;5(1):e000848
pubmed: 30886736
Ann Rheum Dis. 2015 Jan;74(1):52-9
pubmed: 23956249
Blood. 2008 Jan 15;111(2):643-50
pubmed: 17925485
Ann Rheum Dis. 2005 Jan;64(1):127-9
pubmed: 15051621

Auteurs

Berthold Hoppe (B)

Institute of Laboratory Medicine, Unfallkrankenhaus Berlin, Berlin, Germany berthold.hoppe@charite.de.
Institute of Laboratory Medicine and Pathobiochemistry, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Christian Schwedler (C)

Institute of Laboratory Medicine and Pathobiochemistry, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Hildrun Haibel (H)

Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Maryna Verba (M)

Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Fabian Proft (F)

Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Mikhail Protopopov (M)

Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Hans-Gert Heuft (HG)

Institute of Transfusion Medicine, Otto-von-Guericke Universität Magdeburg, Magdeburg, Germany.

Valeria Rios Rodriguez (V)

Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Anke Edelmann (A)

Department of Molecular Diagnostics, Labor Berlin, Berlin, Germany.

Martin Rudwaleit (M)

Department of Internal Medicine and Rheumatology, Klinikum Bielefeld Rosenhöhe, Bielefeld, Germany.

Joachim Sieper (J)

Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Denis Poddubnyy (D)

Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH